Therefore, drugs targeting SHMT can block multiple metabolic pathways downstream of 1C metabolism (e.g., DNA and RNA synthesis), indicating that SHMT is a potential target of therapeutic agents directed at various viruses, bacteria and parasite infections, as well as cancer. This evidence concerns the gene SHMT2 and cancer.